SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices

European Journal of Pharmacology

Volumn 450, Issue 3, 2002, Pages 253-257

  Tebano, Maria Teresa ^a   Domenici, Maria Rosaria ^a   Popoli, Patrizia ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Adenosine A2A receptor; Hippocampus; Neuroprotection; Quinolinic acid; Striatum

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2 RECEPTOR; QUINOLINIC ACID;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BINDING; DRUG CONCENTRATION; DRUG EFFECT; ELECTRIC POTENTIAL; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; BINDING SITES; CORPUS STRIATUM; DRUG ANTAGONISM; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; HIPPOCAMPUS; MALE; PYRIMIDINES; QUINOLINIC ACID; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; TIME FACTORS; TRIAZOLES;

EID: 0037199692     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02148-9     Document Type: Article

References (21)

1. Bona E., Aden U., Gilland E., Fredholm B.B., Hagberg H. Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists. Neuropharmacology. 36:1997;1327-1338.
2. Calabresi P., Centonze D., Pisani A., Bernardi G. Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses. J. Neurosci. 17:1997;4509-4516.
3. (2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19:1999;9192-9200.
4. 2A adenosine receptor inactivation in a model of Parkinson's disease. J. Neurosci. 21 RC 143:2001;1-6.
5. Chergui K., Bouron A., Normand E., Mulle C. Functional GluR6 kainate receptors in the striatum: indirect downregulation of synaptic transmission. J. Neurosci. 20:2000;2175-2182.
6. (2A) receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;261-271.
7. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
8. 2 receptor antagonist, reduces cerebral ischemic injury in the mongolian gerbil. Life Sci. 55:1994;PL61-PL65.
9. Impagniatiello F., Bastia E., Ongini E., Monopoli A. Adenosine receptors in neurological disorders. Emerg. Ther. Targets. 4:2000;635-664.
10. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 251:1989;888-893.
11. 2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br. J. Pharmacol. 128:1999;1035-1044.
12. 3H]-CGS 21680 in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;539-541.
13. 2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. NeuroReport. 9:1998;3955-3959.
14. Ongini E., Dionisotti S., Gessi S., Irenius E., Fredholm B.B. Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 359:1999;7-10.
15. Orlando L.R., Alsdorf S.A., Penney J.B. Jr., Young A.B. The role of Group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity. Exp. Neurol. 167:2001;196-204.
16. Perkins M.N., Stone T.W. Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system. J. Pharm. Exp. Ther. 226:1983;551-557.
17. 2A receptors reduces, through a presynaptic mechanism, quinolinic acid-induced excitoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. J. Neurosci. 22:2002;1967-1975.
18. 2A receptors in the rat central nervous system. J. Comp. Neurol. 401:1998;163-186.
19. Sebastiâo A.M., de Mendoça A., Moreira T., Ribeiro A. Activation of synaptic NMDA receptors by action potential-dependent release of transmitter during hypoxia impairs recovery of synaptic transmission on reoxygenation. J. Neurosci. 21:2001;8564-8571.
20. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45:1993;309-379.
21. 3 adenosine receptors. Life Sci. 63:1998;PL81-PL87.